Project Grant R01AG086764
Award Date
6/1/24
Completion Date
3/31/29
Dollars Obligated
$706K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
New York, NY 10032, USA
Similar Awards
The federal Project Grant award in the amount of $2,413,601.00, issued by the National Institute on Aging (CFDA 93.866 - Aging Research), supports research to investigate the role of extracellular vesicles, specifically mitovesicles, in the pathogenesis of Alzheimer's disease. The award, with a project period from June 15, 2024 to May 31, 2027, will fund in vitro and in vivo studies to examine the generation, secretion, uptake, and intracellular fate of mitovesicles in the brain under both...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $700,999 to The Johns Hopkins University to conduct a comprehensive assessment of mitochondrial DNA (mtDNA) variation and its associations with plasma metabolites, proteins, and aging-related health outcomes. The researchers will leverage whole-genome sequencing, metabolomics, and proteomics data from up to 680,000 participants to identify novel biomarkers of mitochondrial function and explore...
This federal Project Grant award, provided by the National Institute on Aging under CFDA Program 93.866 - Aging Research, supports an interdisciplinary investigation into the functional asymmetry and topological restructuring of mitochondrial networks during cellular aging. The $388,067 grant, awarded to Northwestern University on September 20, 2024, aims to mechanistically investigate the sequence of subcellular events that lead to asymmetric mitochondrial segregation and its impact on...
This $445,144 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) will fund a study examining the relationship between blood-based mitochondrial bioenergetic capacity, socioeconomic position, and physical functioning in older adults. The study aims to: 1) test the reliability and validity of using frozen blood samples to measure systemic mitochondrial bioenergetic capacity via an innovative respirometry technique; 2) examine the association between...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $472,500.00 to the J. David Gladstone Institutes to conduct research on using hypoxic (low oxygen) therapy to treat mitochondrial diseases. The research aims to expand the understanding of how hypoxia can prevent and reverse neurological damage caused by mitochondrial electron transport chain deficiencies. The project will investigate two potential mechanisms: activation of the hypoxia-inducible...
This federal Project Grant award, valued at $173,788 and provided by the National Institute on Aging (CFDA 93.866 Aging Research), supports a five-year research program at the University of California, Los Angeles (UCLA) to define the scope and functional consequences of mitochondrial genome mutations in skin tissue aging. The principal investigator will utilize advanced sequencing methods and induced pluripotent cell models to map age-associated mitochondrial DNA mutations in skin tissue,...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $827,764 to the University of Southern California to investigate the potential protective effects of the mitochondrial-derived peptide MOTS-C on age-related cognitive decline and Alzheimer's disease pathology. The research aims to study how MOTS-C may target systemic phenotypes associated with the Alzheimer's disease risk factor APOE4 across age and in the presence of Alzheimer's and tau...
This federal Project Grant award, provided by the National Institute on Aging under the Aging Research program (CFDA 93.866), supports an interdisciplinary research project to study human-specific vulnerabilities and compensatory adaptations in midbrain dopaminergic neurons. The $866,764 award, with an initial term from August 2024 to July 2029, will enable the primary awardee, the Regents of the University of California, San Francisco (UCSF), to investigate how the evolutionary expansion of the...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $1,394,250 to the Icahn School of Medicine at Mount Sinai to study the molecular mechanisms underlying healthy versus pathological aging in human brain and adipose tissue, and the inter-organ communication between these tissues. The key objectives are to: 1) Identify common gene regulation patterns between brain and adipose tissues in pathological aging subgroups, and genes putatively...
This federal Project Grant award, with funding of $105,952 from the National Institute on Aging's Aging Research program (CFDA 93.866), supports the identification and characterization of clonal expansions in aging and aging-related diseases. The key objectives are to: Develop tools to accurately identify somatic variants at scale from publicly available data, and apply these tools to analyze the clonal architecture of conditions like diabetes, obesity, and hypertension in older individuals....